Deoxyribonucleic Acid (DNA) Manufacturing Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Deoxyribonucleic Acid (DNA) Manufacturing Market Size Outlook: How Fast Will Revenue Grow Through 2030?
In recent years, the market for deoxyribonucleic acid (DNA) manufacturing has experienced rapid expansion. Its value is projected to rise from $5.58 billion in 2025 to $6.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.7%. Several factors contributed to this historical growth, including restricted availability of high-quality plasmid and synthetic DNA, dependence on conventional chemical DNA synthesis techniques, increased research and development in cell and gene therapies, a surge in academic and industrial research efforts, and a growing need for oligonucleotide-based medications.
The market for deoxyribonucleic acid (DNA) manufacturing is expected to experience rapid expansion during the next several years. By 2030, it is projected to reach $11.95 billion, driven by a compound annual growth rate (CAGR) of 16.4%. Key drivers for this growth in the forecast period include progress in enzymatic and chemical DNA synthesis techniques, the growth of gene therapy and vaccine development programs, broader implementation of GMP-grade DNA production, an increased need for lengthy and intricate DNA constructs, and the incorporation of automated DNA manufacturing systems along with digital workflows. Significant trends shaping the forecast period consist of a heightened need for GMP-grade DNA for therapeutic uses, expanded output of plasmid and synthetic DNA for vaccines, wider use of gene synthesis and codon optimization services, greater reliance on oligonucleotide synthesis for applications such as PCR, siRNA, and antisense technologies, and the integration of DNA manufacturing into cell and gene therapy initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
Deoxyribonucleic Acid (DNA) Manufacturing Market Expansion Supported By Key Demand Factors
The growing need for gene therapies is anticipated to accelerate the expansion of the deoxyribonucleic acid (DNA) manufacturing market in the coming period. Gene therapies involve methods designed to alter or replace defective genes to address or prevent illnesses, whereas personalized medicine customizes medical treatments based on an individual’s genetic, biological, and lifestyle factors. This rising demand for gene therapies is fueled by the increasing occurrence of genetic conditions like cystic fibrosis, sickle cell disease, and some forms of hereditary blindness. DNA manufacturing facilitates gene therapies by supplying the high-grade, tailored DNA sequences required to create and deliver therapeutic genes capable of fixing or substituting faulty genetic material within patients. A case in point is January 2024, when the American Society of Gene & Cell Therapy, a US-based entity, reported that the number of pre-registration gene therapy initiatives had grown by 83% in the fourth quarter of 2024 compared to the third quarter of the same year, marking the most significant increase in over twelve months. Consequently, the escalating demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.
Deoxyribonucleic Acid (DNA) Manufacturing Market Segmentation And Category Breakdown
The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –
1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis
2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade
3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA
2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA
3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis
4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos
Deoxyribonucleic Acid (DNA) Manufacturing Market Growth Trends Influencing Competitive Dynamics
Key players in the DNA manufacturing industry are prioritizing the development of advanced strategies, particularly GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy solutions. This type of production involves creating plasmid DNA under Good Manufacturing Practice (GMP) standards, which are regulatory requirements designed to guarantee the quality, safety, and uniformity of biopharmaceutical products. As an example, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), introduced GMP Plasmid DNA Manufacturing Services in Hopewell, featuring in-house analytical testing, method development, and project management. These services provide distinct advantages, such as integrated process development, analytical testing, method development, and project management, which remove the need for multiple vendors and accelerate development timelines. The offering ensures superior output with at least 85% supercoiled plasmid DNA content and reduces contamination risks. Additionally, ProBio supplies GMP-like plasmids within four weeks and full GMP-grade plasmids in three months.
Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Analysis Of Major Industry Participants
Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.
Access The Complete Deoxyribonucleic Acid (DNA) Manufacturing Market Report:
Deoxyribonucleic Acid (DNA) Manufacturing Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
